NRIX Financial Statements | Balance Sheet, Income & Cash Flow Analysis
The financial statements for NRIX (NRIX) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.
See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.
Financial Statements
Related peers
Compare More →| EYPT EyePoint Pharmaceuticals, Inc. | $14.63 +2.02% |
| R Ryder System, Inc. | $212.05 -3.54% |
| KURA Kura Oncology, Inc. | $9.05 -0.98% |
| KOD Kodiak Sciences Inc. | $41.98 -6.86% |
| PHAT Phathom Pharmaceuticals, Inc. | $12.79 +0.95% |
| TNGX Tango Therapeutics, Inc. | $25.33 +5.28% |
| Peer | Price | Change | Market Cap | PE | EPS | Div Yield (TTM) | Analyst Rating | Volume |
|---|---|---|---|---|---|---|---|---|
| EYPT EyePoint Pharmaceuticals, Inc. | $14.63 | +2.02% | 1.22 B | -4.62 | -3.17 | 0.00% | Buy | 580 |
| R Ryder System, Inc. | $212.05 | -3.54% | 8.36 B | 17.67 | 12.00 | 1.61% | Buy | 556 |
| KURA Kura Oncology, Inc. | $9.05 | -0.98% | 799.38 M | -2.85 | -3.18 | 0.00% | Buy | 839 |
| KOD Kodiak Sciences Inc. | $41.98 | -6.86% | 2.22 B | -9.72 | -4.32 | 0.00% | Buy | 732 |
| PHAT Phathom Pharmaceuticals, Inc. | $12.79 | +0.95% | 1.01 B | -4.22 | -3.03 | 0.00% | Buy | 490 |
| TNGX Tango Therapeutics, Inc. | $25.33 | +5.28% | 2.94 B | -30.15 | -0.84 | 0.00% | Buy | 4.38 |
Frequently Asked Questions
What are NRIX's latest financial results?
Review NRIX's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.
How has NRIX's revenue and net income changed over time?
Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.
What is NRIX's cash flow situation and liquidity?
Cash flow statements reveal how NRIX generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.
How does NRIX's financial performance compare to industry peers?
Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether NRIX is outperforming or lagging within its sector.
Are NRIX's financial statements showing sustainable profitability?
By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether NRIX's profits are repeatable and supported by strong fundamentals.